rs28730867

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006063.3(KLHL41):​c.8C>T​(p.Ser3Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 1,609,052 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0096 ( 10 hom., cov: 32)
Exomes 𝑓: 0.014 ( 196 hom. )

Consequence

KLHL41
NM_006063.3 missense

Scores

1
4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 7.57

Publications

12 publications found
Variant links:
Genes affected
KLHL41 (HGNC:16905): (kelch like family member 41) This gene is a member of the kelch-like family. The encoded protein contains a BACK domain, a BTB/POZ domain, and 5 Kelch repeats. This protein is thought to function in skeletal muscle development and maintenance. Mutations in this gene have been associated with nemaline myopathy (NM), a rare congenital muscle disorder. [provided by RefSeq, Mar 2015]
KLHL41 Gene-Disease associations (from GenCC):
  • nemaline myopathy 9
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006108731).
BP6
Variant 2-169509786-C-T is Benign according to our data. Variant chr2-169509786-C-T is described in ClinVar as Benign. ClinVar VariationId is 259913.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00958 (1459/152296) while in subpopulation NFE AF = 0.0156 (1064/68022). AF 95% confidence interval is 0.0149. There are 10 homozygotes in GnomAd4. There are 706 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL41NM_006063.3 linkc.8C>T p.Ser3Phe missense_variant Exon 1 of 6 ENST00000284669.2 NP_006054.2 O60662-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL41ENST00000284669.2 linkc.8C>T p.Ser3Phe missense_variant Exon 1 of 6 1 NM_006063.3 ENSP00000284669.1 O60662-1
ENSG00000251569ENST00000513963.1 linkc.925-4788C>T intron_variant Intron 11 of 15 2 ENSP00000424363.1 E9PBE3

Frequencies

GnomAD3 genomes
AF:
0.00957
AC:
1457
AN:
152178
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00246
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.00720
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.00914
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00960
AC:
2370
AN:
246946
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.00265
Gnomad AMR exome
AF:
0.00448
Gnomad ASJ exome
AF:
0.00555
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.00869
Gnomad NFE exome
AF:
0.0149
Gnomad OTH exome
AF:
0.00989
GnomAD4 exome
AF:
0.0143
AC:
20869
AN:
1456756
Hom.:
196
Cov.:
32
AF XY:
0.0142
AC XY:
10319
AN XY:
724688
show subpopulations
African (AFR)
AF:
0.00257
AC:
86
AN:
33408
American (AMR)
AF:
0.00537
AC:
239
AN:
44532
Ashkenazi Jewish (ASJ)
AF:
0.00639
AC:
166
AN:
25958
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39690
South Asian (SAS)
AF:
0.00707
AC:
608
AN:
85948
European-Finnish (FIN)
AF:
0.00829
AC:
417
AN:
50318
Middle Eastern (MID)
AF:
0.00782
AC:
45
AN:
5752
European-Non Finnish (NFE)
AF:
0.0168
AC:
18633
AN:
1110864
Other (OTH)
AF:
0.0111
AC:
670
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1046
2091
3137
4182
5228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00958
AC:
1459
AN:
152296
Hom.:
10
Cov.:
32
AF XY:
0.00948
AC XY:
706
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00245
AC:
102
AN:
41574
American (AMR)
AF:
0.00719
AC:
110
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4826
European-Finnish (FIN)
AF:
0.00914
AC:
97
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0156
AC:
1064
AN:
68022
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
73
146
220
293
366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0141
Hom.:
51
Bravo
AF:
0.00885
TwinsUK
AF:
0.0227
AC:
84
ALSPAC
AF:
0.0184
AC:
71
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0130
AC:
112
ExAC
AF:
0.0100
AC:
1217
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0154
EpiControl
AF:
0.0157

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nemaline myopathy 9 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.035
T
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.1
L
PhyloP100
7.6
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.65
N
REVEL
Benign
0.17
Sift
Benign
0.036
D
Sift4G
Benign
0.067
T
Polyphen
0.94
P
Vest4
0.42
MPC
0.62
ClinPred
0.013
T
GERP RS
5.0
PromoterAI
0.00050
Neutral
Varity_R
0.17
gMVP
0.66
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28730867; hg19: chr2-170366296; COSMIC: COSV52930929; COSMIC: COSV52930929; API